Latest Insider Transactions at Assembly Biosciences, Inc. (ASMB)
This section provides a real-time view of insider transactions for Assembly Biosciences, Inc. (ASMB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ASSEMBLY BIOSCIENCES, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ASSEMBLY BIOSCIENCES, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 25
2024
|
Alexander Schornstein > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
7,976
+0.55%
|
$111,664
$14.93 P/Share
|
|
Nov 22
2024
|
Alexander Schornstein > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
17,024
+2.31%
|
$238,336
$14.87 P/Share
|
|
Nov 18
2024
|
Nicole S White Chief Manufacturing Officer |
SELL
Open market or private sale
|
Direct |
40
-0.34%
|
$640
$16.29 P/Share
|
|
Oct 08
2024
|
Alexander Schornstein > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
10,000
+1.4%
|
$140,000
$14.58 P/Share
|
|
Oct 03
2024
|
Jason A Okazaki CEO and President |
SELL
Open market or private sale
|
Direct |
197
-1.3%
|
$2,758
$14.81 P/Share
|
|
Oct 03
2024
|
Nicole S White Chief Manufacturing Officer |
SELL
Open market or private sale
|
Direct |
157
-1.3%
|
$2,198
$14.81 P/Share
|
|
Aug 02
2024
|
Nicole S White Chief Manufacturing Officer |
SELL
Open market or private sale
|
Direct |
785
-6.11%
|
$10,990
$14.23 P/Share
|
|
Aug 02
2024
|
Jason A Okazaki CEO and President |
SELL
Open market or private sale
|
Direct |
981
-6.1%
|
$13,734
$14.23 P/Share
|
|
Jul 05
2024
|
Alexander Schornstein > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
4,438
+0.64%
|
$53,256
$12.52 P/Share
|
|
Jul 03
2024
|
Alexander Schornstein > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
4,562
+0.66%
|
$54,744
$12.29 P/Share
|
|
Jun 17
2024
|
Gilead Sciences Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
179,500
+12.39%
|
-
|
|
May 23
2024
|
John G Mc Hutchison |
SELL
Open market or private sale
|
Direct |
2,117
-9.98%
|
$29,638
$14.93 P/Share
|
|
May 23
2024
|
Jeanette M Bjorkquist Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
24
-0.76%
|
$336
$14.93 P/Share
|
|
May 23
2024
|
Jason A Okazaki CEO and President |
SELL
Open market or private sale
|
Direct |
549
-3.3%
|
$7,686
$14.93 P/Share
|
|
May 23
2024
|
Nicole S White Chief Manufacturing Officer |
SELL
Open market or private sale
|
Direct |
172
-1.32%
|
$2,408
$14.93 P/Share
|
|
Apr 30
2024
|
Nicole S White Chief Manufacturing Officer |
SELL
Open market or private sale
|
Direct |
1,255
-8.79%
|
$15,060
$12.71 P/Share
|
|
Apr 30
2024
|
Jason A Okazaki CEO and President |
SELL
Open market or private sale
|
Direct |
1,569
-8.72%
|
$18,828
$12.71 P/Share
|
|
Apr 29
2024
|
Nicole S White Chief Manufacturing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,333
+18.92%
|
-
|
|
Apr 29
2024
|
William E Iv Delaney Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,333
+17.14%
|
-
|
|
Apr 29
2024
|
Jason A Okazaki CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
4,166
+18.8%
|
-
|
|
Apr 01
2024
|
John G Mc Hutchison |
SELL
Open market or private sale
|
Direct |
1,206
-5.38%
|
$15,678
$13.07 P/Share
|
|
Apr 01
2024
|
Jeanette M Bjorkquist Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
114
-3.48%
|
$1,482
$13.07 P/Share
|
|
Apr 01
2024
|
Nicole S White Chief Manufacturing Officer |
SELL
Open market or private sale
|
Direct |
197
-1.77%
|
$2,561
$13.07 P/Share
|
|
Apr 01
2024
|
Jason A Okazaki CEO and President |
SELL
Open market or private sale
|
Direct |
354
-2.5%
|
$4,602
$13.07 P/Share
|
|
Mar 29
2024
|
Jeanette M Bjorkquist Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
850
+20.58%
|
-
|
|
Mar 27
2024
|
Jason A Okazaki CEO and President |
SELL
Open market or private sale
|
Direct |
392
-2.69%
|
$4,704
$12.87 P/Share
|
|
Jan 18
2024
|
Alexander Schornstein > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
345,086
+4.03%
|
$0
$0.8 P/Share
|
|
Jan 17
2024
|
Alexander Schornstein > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
299,994
+3.67%
|
$0
$0.78 P/Share
|
|
Nov 21
2023
|
Alexander Schornstein > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
100,000
+1.3%
|
$0
$0.67 P/Share
|
|
Nov 20
2023
|
Alexander Schornstein > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
300,000
+3.86%
|
$0
$0.72 P/Share
|
|
Nov 17
2023
|
Nicole S White Chief Manufacturing Officer |
SELL
Open market or private sale
|
Direct |
477
-0.51%
|
$0
$0.69 P/Share
|
|
Oct 03
2023
|
Nicole S White Chief Manufacturing Officer |
SELL
Open market or private sale
|
Direct |
1,891
-1.97%
|
$0
$0.8 P/Share
|
|
Oct 03
2023
|
William E Iv Delaney Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,891
-1.24%
|
$0
$0.8 P/Share
|
|
Oct 03
2023
|
Jason A Okazaki CEO and President |
SELL
Open market or private sale
|
Direct |
2,363
-1.33%
|
$0
$0.8 P/Share
|
|
Oct 02
2023
|
Nicole S White Chief Manufacturing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+9.42%
|
-
|
|
Oct 02
2023
|
William E Iv Delaney Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+6.14%
|
-
|
|
Oct 02
2023
|
Jason A Okazaki CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+6.59%
|
-
|
|
Aug 02
2023
|
William E Iv Delaney Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
9,461
-6.22%
|
$9,461
$1.09 P/Share
|
|
Aug 02
2023
|
Jason A Okazaki CEO and President |
SELL
Open market or private sale
|
Direct |
11,827
-6.7%
|
$11,827
$1.09 P/Share
|
|
Jul 24
2023
|
Jeanette M Bjorkquist Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
844
-3.07%
|
$844
$1.07 P/Share
|
|
Jun 22
2023
|
William E Iv Delaney Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+20.81%
|
-
|
|
Jun 22
2023
|
Jason A Okazaki CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+22.06%
|
-
|
|
May 30
2023
|
William E Iv Delaney Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,232
-3.63%
|
$0
$0.96 P/Share
|
|
May 23
2023
|
John G Mc Hutchison |
SELL
Open market or private sale
|
Direct |
25,972
-13.31%
|
$25,972
$1.04 P/Share
|
|
May 23
2023
|
Jeanette M Bjorkquist Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
274
-0.99%
|
$274
$1.04 P/Share
|
|
May 23
2023
|
William E Iv Delaney Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,561
-5.33%
|
$6,561
$1.04 P/Share
|
|
May 23
2023
|
Jason A Okazaki CEO and President |
SELL
Open market or private sale
|
Direct |
6,561
-4.93%
|
$6,561
$1.04 P/Share
|
|
May 22
2023
|
John G Mc Hutchison |
BUY
Grant, award, or other acquisition
|
Direct |
117,500
+28.48%
|
-
|
|
May 22
2023
|
Jeanette M Bjorkquist Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+5.12%
|
-
|
|
May 22
2023
|
William E Iv Delaney Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+22.15%
|
-
|